Skip to Main Navigation
Skip to Page Content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
https://ntp.niehs.nih.gov/go/19278

TDMS Study 96017-06 Pathology Tables

NTP Experiment-Test: 96017-06         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                         WATER DISINFECTION BYPRODUCTS (DIBROMOACETIC ACID)                    Date: 05/19/04
Route: DOSED WATER                                                                                                Time: 09:07:01

                                                          FINAL#1 MICE




       Facility:  Southern Research Institute

       Chemical CAS #:  631-64-1

       Lock Date:  11/15/02

       Cage Range:  All

       Reasons For Removal:    All

       Removal Date Range:     All

       Treatment Groups:       Include All


































a  Number of animals examined microscopically at site and number of animals with lesion

                                                              Page   1


NTP Experiment-Test: 96017-06         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                         WATER DISINFECTION BYPRODUCTS (DIBROMOACETIC ACID)                    Date: 05/19/04    
Route: DOSED WATER                                                                                                Time: 09:07:01    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         B6C3F1 MICE FEMALE                        0 MG/L       50 MG/L      500 MG/L     1000                                      
                                                                                          MG/L                                      
____________________________________________________________________________________________________________________________________
                                                                                                                                    
DISPOSITION SUMMARY                                                                                                                 
                                                                                                                                    
  Animals Initially In Study                          50           50           50           50                                     
  Early Deaths                                                                                                                      
    Natural Death                                     10           13           13           11                                     
    Moribund Sacrifice                                 2            2            5            7                                     
  Survivors                                                                                                                         
    Terminal Sacrifice                                38           35           31           32                                     
    Natural Death                                                                1                                                  
                                                                                                                                    
  Animals Examined Microscopically                    50           50           50           50                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Intestine Large, Rectum                            (49)         (49)         (48)         (49)                                   
      Ulcer                                                                      1 (2%)                                             
   Intestine Large, Cecum                             (47)         (46)         (49)         (46)                                   
      Edema                                            2 (4%)       1 (2%)                    3 (7%)                                
      Inflammation, Chronic                                         1 (2%)                    1 (2%)                                
      Epithelium, Hyperplasia                                                    1 (2%)                                             
   Intestine Small, Duodenum                          (46)         (48)         (48)         (45)                                   
      Epithelium, Hyperplasia                                       1 (2%)                                                          
   Intestine Small, Jejunum                           (46)         (47)         (49)         (43)                                   
      Hyperplasia, Lymphoid                                         2 (4%)                    2 (5%)                                
   Intestine Small, Ileum                             (45)         (47)         (47)         (46)                                   
      Inflammation, Chronic                                         1 (2%)                                                          
   Liver                                              (49)         (50)         (50)         (49)                                   
      Angiectasis                                      1 (2%)       2 (4%)                                                          
      Basophilic Focus                                              1 (2%)       3 (6%)       3 (6%)                                
      Clear Cell Focus                                 3 (6%)       1 (2%)       8 (16%)      5 (10%)                               
      Eosinophilic Focus                               7 (14%)      6 (12%)     10 (20%)      9 (18%)                               
      Hematopoietic Cell Proliferation                 2 (4%)       4 (8%)       2 (4%)       2 (4%)                                
      Hepatodiaphragmatic Nodule                                                              2 (4%)                                
      Hyperplasia, Lymphoid                            2 (4%)       1 (2%)                                                          
      Infarct                                                                                 1 (2%)                                
      Infiltration Cellular, Mixed Cell                7 (14%)      7 (14%)      4 (8%)       9 (18%)                               
      Inflammation, Chronic Active                                               1 (2%)                                             
      Mixed Cell Focus                                 2 (4%)       6 (12%)      3 (6%)       1 (2%)                                
      Necrosis, Focal                                  3 (6%)       2 (4%)       3 (6%)       2 (4%)                                
      Tension Lipidosis                                1 (2%)       3 (6%)                                                          
      Centrilobular, Necrosis                                       1 (2%)       4 (8%)       4 (8%)                                
      Hepatocyte, Vacuolization Cytoplasmic            2 (4%)       7 (14%)      4 (8%)       2 (4%)                                
      Kupffer Cell, Pigmentation                       3 (6%)                                 3 (6%)                                
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page    2                                                              
                                                                                                                                   
NTP Experiment-Test: 96017-06         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                         WATER DISINFECTION BYPRODUCTS (DIBROMOACETIC ACID)                    Date: 05/19/04    
Route: DOSED WATER                                                                                                Time: 09:07:01    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         B6C3F1 MICE FEMALE                        0 MG/L       50 MG/L      500 MG/L     1000                                      
                                                                                          MG/L                                      
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
   Mesentery                                          (28)         (20)         (16)         (19)                                   
      Fat, Necrosis                                   22 (79%)     18 (90%)     11 (69%)     13 (68%)                               
   Pancreas                                           (49)         (49)         (49)         (47)                                   
      Atrophy                                                       1 (2%)       1 (2%)       3 (6%)                                
      Cyst                                                                       1 (2%)       3 (6%)                                
      Inflammation, Chronic                                                                   1 (2%)                                
      Acinus, Cytoplasmic Alteration                   1 (2%)                                                                       
   Salivary Glands                                    (50)         (49)         (50)         (50)                                   
      Hyperplasia, Lymphoid                           15 (30%)     13 (27%)     16 (32%)     10 (20%)                               
   Stomach, Forestomach                               (49)         (50)         (50)         (49)                                   
      Erosion                                                       1 (2%)                                                          
      Inflammation, Chronic                            1 (2%)       2 (4%)       2 (4%)       1 (2%)                                
      Ulcer                                            1 (2%)       1 (2%)       1 (2%)       3 (6%)                                
      Epithelium, Hyperplasia                          4 (8%)       5 (10%)                   4 (8%)                                
   Stomach, Glandular                                 (49)         (50)         (50)         (49)                                   
      Erosion                                                       1 (2%)                    1 (2%)                                
      Pylorus, Epithelium, Hyperplasia, Atypical                    1 (2%)                                                          
   Tooth                                                                        (1)                                                 
      Malformation                                                               1 (100%)                                           
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Blood Vessel                                       (1)          (1)          (1)                                                 
      Hypertrophy                                                                1 (100%)                                           
      Inflammation, Chronic Active                                               1 (100%)                                           
   Heart                                              (50)         (49)         (50)         (50)                                   
      Cardiomyopathy                                                             1 (2%)       1 (2%)                                
      Inflammation, Chronic                                         1 (2%)                    1 (2%)                                
      Inflammation, Chronic Active                                                            1 (2%)                                
      Mineralization                                                1 (2%)       1 (2%)       2 (4%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Cortex                                     (50)         (50)         (50)         (49)                                   
      Accessory Adrenal Cortical Nodule                9 (18%)     11 (22%)      6 (12%)      9 (18%)                               
      Hyperplasia, Focal                                            2 (4%)                    1 (2%)                                
      Hypertrophy, Focal                                            1 (2%)                                                          
      Capsule, Hyperplasia                                          1 (2%)                    1 (2%)                                
   Adrenal Medulla                                    (50)         (50)         (50)         (49)                                   
      Hyperplasia                                                   2 (4%)       1 (2%)       1 (2%)                                
   Islets, Pancreatic                                 (49)         (49)         (49)         (46)                                   
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page    3                                                              
                                                                                                                                   
NTP Experiment-Test: 96017-06         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                         WATER DISINFECTION BYPRODUCTS (DIBROMOACETIC ACID)                    Date: 05/19/04    
Route: DOSED WATER                                                                                                Time: 09:07:01    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         B6C3F1 MICE FEMALE                        0 MG/L       50 MG/L      500 MG/L     1000                                      
                                                                                          MG/L                                      
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ENDOCRINE SYSTEM - CONT                                                                                                             
      Hyperplasia                                      2 (4%)       5 (10%)      3 (6%)       3 (7%)                                
   Parathyroid Gland                                  (45)         (49)         (47)         (49)                                   
      Cyst                                             2 (4%)       1 (2%)       1 (2%)       3 (6%)                                
   Pituitary Gland                                    (47)         (49)         (49)         (49)                                   
      Pars Distalis, Angiectasis                       2 (4%)       3 (6%)       1 (2%)       1 (2%)                                
      Pars Distalis, Cyst                              2 (4%)       2 (4%)       1 (2%)       1 (2%)                                
      Pars Distalis, Hyperplasia, Focal                4 (9%)       9 (18%)      4 (8%)       7 (14%)                               
      Pars Intermedia, Hyperplasia, Focal              1 (2%)                                                                       
   Thyroid Gland                                      (50)         (50)         (50)         (50)                                   
      Degeneration, Cystic                            10 (20%)     26 (52%)     16 (32%)     14 (28%)                               
      Follicular Cell, Hyperplasia                     8 (16%)      1 (2%)       1 (2%)       2 (4%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Clitoral Gland                                     (50)         (48)         (48)         (49)                                   
      Cyst                                                          1 (2%)                                                          
   Ovary                                              (49)         (47)         (47)         (49)                                   
      Angiectasis                                      5 (10%)      3 (6%)       9 (19%)      7 (14%)                               
      Cyst                                            14 (29%)     12 (26%)     14 (30%)     22 (45%)                               
      Corpus Luteum, Hyperplasia                       1 (2%)       1 (2%)                                                          
      Granulosa Cell, Hyperplasia                      1 (2%)                                                                       
      Interstitial Cell, Hyperplasia                                                          1 (2%)                                
   Uterus                                             (50)         (50)         (50)         (50)                                   
      Angiectasis                                                   4 (8%)       1 (2%)       2 (4%)                                
      Hyperplasia, Cystic                             44 (88%)     42 (84%)     44 (88%)     39 (78%)                               
      Inflammation, Chronic                            1 (2%)       1 (2%)       1 (2%)                                             
      Metaplasia, Squamous                             1 (2%)                    1 (2%)       1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Bone Marrow                                        (50)         (50)         (50)         (50)                                   
      Hyperplasia                                     20 (40%)     26 (52%)     24 (48%)     20 (40%)                               
      Infiltration Cellular, Mast Cell                              1 (2%)                                                          
   Lymph Node                                         (12)         (13)         (11)         (8)                                    
      Hyperplasia, Lymphoid                                         1 (8%)                                                          
      Bronchial, Hemorrhage                                         1 (8%)                                                          
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page    4                                                              
                                                                                                                                   
NTP Experiment-Test: 96017-06         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                         WATER DISINFECTION BYPRODUCTS (DIBROMOACETIC ACID)                    Date: 05/19/04    
Route: DOSED WATER                                                                                                Time: 09:07:01    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         B6C3F1 MICE FEMALE                        0 MG/L       50 MG/L      500 MG/L     1000                                      
                                                                                          MG/L                                      
____________________________________________________________________________________________________________________________________
                                                                                                                                    
HEMATOPOIETIC SYSTEM - CONT                                                                                                         
      Bronchial, Hyperplasia, Lymphoid                              1 (8%)                                                          
      Deep Cervical, Hemorrhage                                                               1 (13%)                               
      Iliac, Hematopoietic Cell Proliferation                       1 (8%)                                                          
      Iliac, Hemorrhage                                1 (8%)                                 1 (13%)                               
      Iliac, Hyperplasia, Lymphoid                     1 (8%)       1 (8%)       1 (9%)       2 (25%)                               
      Iliac, Pigmentation                              1 (8%)                                                                       
      Inguinal, Hematopoietic Cell Proliferation                    1 (8%)                                                          
      Inguinal, Hyperplasia, Lymphoid                               2 (15%)                                                         
      Mediastinal, Hemorrhage                          1 (8%)                                                                       
      Mediastinal, Hyperplasia, Lymphoid               1 (8%)       1 (8%)       1 (9%)       1 (13%)                               
      Mediastinal, Pigmentation                        1 (8%)                                                                       
      Pancreatic, Hyperplasia, Lymphoid                                          1 (9%)                                             
      Renal, Hyperplasia, Lymphoid                     1 (8%)                    1 (9%)       1 (13%)                               
   Lymph Node, Mandibular                             (48)         (49)         (47)         (50)                                   
      Atrophy                                                       1 (2%)       1 (2%)       1 (2%)                                
      Hematopoietic Cell Proliferation                 1 (2%)       1 (2%)                    2 (4%)                                
      Hemorrhage                                                    2 (4%)       2 (4%)       1 (2%)                                
      Hyperplasia, Lymphoid                           13 (27%)      6 (12%)      8 (17%)      9 (18%)                               
      Pigmentation                                    18 (38%)     25 (51%)     17 (36%)     23 (46%)                               
   Lymph Node, Mesenteric                             (49)         (49)         (48)         (45)                                   
      Angiectasis                                                                1 (2%)                                             
      Atrophy                                                                    2 (4%)       1 (2%)                                
      Ectasia                                                                    1 (2%)                                             
      Hematopoietic Cell Proliferation                 2 (4%)                    2 (4%)       1 (2%)                                
      Hemorrhage                                       1 (2%)       1 (2%)       1 (2%)       5 (11%)                               
      Hyperplasia, Lymphoid                            8 (16%)      9 (18%)      7 (15%)      5 (11%)                               
      Pigmentation                                                               1 (2%)       1 (2%)                                
   Spleen                                             (50)         (50)         (50)         (48)                                   
      Hematopoietic Cell Proliferation                34 (68%)     42 (84%)     35 (70%)     34 (71%)                               
      Necrosis                                         1 (2%)                                                                       
      Pigmentation                                     5 (10%)      5 (10%)      1 (2%)       2 (4%)                                
      Lymphoid Follicle, Atrophy                                    1 (2%)       2 (4%)       2 (4%)                                
      Lymphoid Follicle, Hyperplasia                   8 (16%)     11 (22%)     14 (28%)     12 (25%)                               
   Thymus                                             (44)         (47)         (47)         (48)                                   
      Atrophy                                          8 (18%)      9 (19%)     11 (23%)     13 (27%)                               
      Hemorrhage                                       1 (2%)                                                                       
      Hyperplasia, Lymphoid                                         3 (6%)       3 (6%)       2 (4%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Mammary Gland                                      (50)         (50)         (50)         (50)                                   
      Hyperplasia                                      5 (10%)      6 (12%)      2 (4%)       5 (10%)                               
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page    5                                                              
                                                                                                                                   
NTP Experiment-Test: 96017-06         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                         WATER DISINFECTION BYPRODUCTS (DIBROMOACETIC ACID)                    Date: 05/19/04    
Route: DOSED WATER                                                                                                Time: 09:07:01    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         B6C3F1 MICE FEMALE                        0 MG/L       50 MG/L      500 MG/L     1000                                      
                                                                                          MG/L                                      
____________________________________________________________________________________________________________________________________
                                                                                                                                    
INTEGUMENTARY SYSTEM - CONT                                                                                                         
   Skin                                               (50)         (50)         (50)         (50)                                   
      Edema                                                         1 (2%)       1 (2%)       1 (2%)                                
      Erosion                                                                    1 (2%)                                             
      Ulcer                                            2 (4%)       1 (2%)       1 (2%)       1 (2%)                                
      Epidermis, Hyperplasia                           2 (4%)       1 (2%)       2 (4%)       1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   Bone                                               (50)         (50)         (50)         (50)                                   
      Myelofibrosis                                    1 (2%)       2 (4%)       1 (2%)       2 (4%)                                
   Skeletal Muscle                                    (3)          (4)          (2)          (5)                                    
      Inflammation, Chronic Active                                                            1 (20%)                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (50)         (49)         (50)         (50)                                   
      Compression                                      1 (2%)       1 (2%)       1 (2%)                                             
      Hemorrhage                                                    2 (4%)                                                          
      Necrosis                                                      1 (2%)       1 (2%)                                             
   Peripheral Nerve                                                (1)          (1)          (1)                                    
      Atrophy                                                                                 1 (100%)                              
   Spinal Cord                                                     (1)          (1)          (1)                                    
      Necrosis                                                      1 (100%)                                                        
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Lung                                               (50)         (50)         (50)         (50)                                   
      Congestion                                                                 2 (4%)                                             
      Hemorrhage                                                    2 (4%)       2 (4%)       3 (6%)                                
      Hyperplasia, Lymphoid                            5 (10%)      5 (10%)      1 (2%)       3 (6%)                                
      Infiltration Cellular, Histiocyte                1 (2%)       2 (4%)       2 (4%)       4 (8%)                                
      Alveolar Epithelium, Hyperplasia                 3 (6%)       3 (6%)                    4 (8%)                                
      Perivascular, Inflammation, Chronic Active                                              1 (2%)                                
   Nose                                               (50)         (50)         (50)         (50)                                   
      Inflammation, Chronic                                                                   1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   Eye                                                (50)         (50)         (50)         (50)                                   
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page    6                                                              
                                                                                                                                   
NTP Experiment-Test: 96017-06         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                         WATER DISINFECTION BYPRODUCTS (DIBROMOACETIC ACID)                    Date: 05/19/04    
Route: DOSED WATER                                                                                                Time: 09:07:01    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         B6C3F1 MICE FEMALE                        0 MG/L       50 MG/L      500 MG/L     1000                                      
                                                                                          MG/L                                      
____________________________________________________________________________________________________________________________________
                                                                                                                                    
SPECIAL SENSES SYSTEM - CONT                                                                                                        
      Atrophy                                                                    1 (2%)                                             
      Cataract                                                                   2 (4%)       2 (4%)                                
      Inflammation, Chronic                            2 (4%)       2 (4%)       3 (6%)       3 (6%)                                
      Cornea, Hyperplasia                              1 (2%)                    4 (8%)                                             
      Cornea, Mineralization                                                                  1 (2%)                                
   Harderian Gland                                    (49)         (50)         (50)         (50)                                   
      Hyperplasia, Focal                               2 (4%)       4 (8%)       4 (8%)       2 (4%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (49)         (50)         (50)         (49)                                   
      Cyst                                                          1 (2%)                    1 (2%)                                
      Hydronephrosis                                                             1 (2%)       1 (2%)                                
      Hyperplasia, Lymphoid                            7 (14%)      2 (4%)       5 (10%)      8 (16%)                               
      Infarct                                          3 (6%)       8 (16%)      6 (12%)      8 (16%)                               
      Nephropathy                                     14 (29%)      8 (16%)     15 (30%)     12 (24%)                               
      Renal Tubule, Accumulation, Hyaline Droplet      1 (2%)       1 (2%)       2 (4%)       2 (4%)                                
      Renal Tubule, Dilatation                                      2 (4%)       1 (2%)       1 (2%)                                
      Renal Tubule, Necrosis                                        1 (2%)                    1 (2%)                                
      Renal Tubule, Pigmentation                       1 (2%)                    3 (6%)       1 (2%)                                
   Urinary Bladder                                    (50)         (49)         (50)         (49)                                   
      Edema                                            2 (4%)                                                                       
      Hyperplasia, Lymphoid                            3 (6%)       5 (10%)      3 (6%)       2 (4%)                                
      Transitional Epithelium, Hyperplasia                                       1 (2%)                                             
                                                                                                                                    
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                             Page    7                                                              
                                                                                                                                   
NTP Experiment-Test: 96017-06         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                         WATER DISINFECTION BYPRODUCTS (DIBROMOACETIC ACID)                    Date: 05/19/04    
Route: DOSED WATER                                                                                                Time: 09:07:01    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         B6C3F1 MICE MALE                          0 MG/L       50 MG/L      500 MG/L     1000                                      
                                                                                          MG/L                                      
____________________________________________________________________________________________________________________________________
                                                                                                                                    
DISPOSITION SUMMARY                                                                                                                 
                                                                                                                                    
  Animals Initially In Study                          50           50           50           50                                     
  Early Deaths                                                                                                                      
    Moribund Sacrifice                                 4            6            3            6                                     
    Natural Death                                     14            6           13           13                                     
  Survivors                                                                                                                         
    Terminal Sacrifice                                31           38           34           31                                     
  Other                                                1                                                                            
                                                                                                                                    
  Animals Examined Microscopically                    49           50           50           50                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Intestine Large, Cecum                             (43)         (49)         (48)         (46)                                   
      Edema                                            2 (5%)       2 (4%)       3 (6%)       1 (2%)                                
      Hyperplasia, Lymphoid                                                      1 (2%)                                             
   Intestine Small, Duodenum                          (42)         (50)         (46)         (48)                                   
      Hyperplasia, Lymphoid                                         1 (2%)                                                          
   Intestine Small, Jejunum                           (44)         (49)         (46)         (45)                                   
      Hyperplasia, Lymphoid                                                      2 (4%)       2 (4%)                                
   Liver                                              (49)         (50)         (50)         (50)                                   
      Angiectasis                                                                1 (2%)                                             
      Basophilic Focus                                 2 (4%)                    1 (2%)       2 (4%)                                
      Clear Cell Focus                                10 (20%)     13 (26%)     23 (46%)     13 (26%)                               
      Congestion                                       1 (2%)                                                                       
      Cyst                                                          1 (2%)                    1 (2%)                                
      Eosinophilic Focus                              15 (31%)     10 (20%)     15 (30%)     17 (34%)                               
      Hematopoietic Cell Proliferation                                                        1 (2%)                                
      Hemorrhage                                       1 (2%)                                                                       
      Hepatodiaphragmatic Nodule                                    1 (2%)                                                          
      Infarct                                          1 (2%)                    1 (2%)                                             
      Infiltration Cellular, Mixed Cell                2 (4%)       4 (8%)       2 (4%)       2 (4%)                                
      Mixed Cell Focus                                 3 (6%)       7 (14%)      8 (16%)      4 (8%)                                
      Necrosis, Focal                                  8 (16%)      7 (14%)      3 (6%)       5 (10%)                               
      Tension Lipidosis                                             1 (2%)       1 (2%)       2 (4%)                                
      Bile Duct, Cyst                                                            1 (2%)                                             
      Bile Duct, Cyst Multilocular                                               1 (2%)                                             
      Centrilobular, Necrosis                          4 (8%)       4 (8%)                    5 (10%)                               
      Hepatocyte, Vacuolization Cytoplasmic            8 (16%)      9 (18%)      4 (8%)      10 (20%)                               
      Kupffer Cell, Pigmentation                       1 (2%)       1 (2%)       1 (2%)       1 (2%)                                
   Mesentery                                          (7)          (7)          (10)         (7)                                    
      Inflammation, Chronic                                                      1 (10%)                                            
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page    8                                                              
                                                                                                                                   
NTP Experiment-Test: 96017-06         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                         WATER DISINFECTION BYPRODUCTS (DIBROMOACETIC ACID)                    Date: 05/19/04    
Route: DOSED WATER                                                                                                Time: 09:07:01    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         B6C3F1 MICE MALE                          0 MG/L       50 MG/L      500 MG/L     1000                                      
                                                                                          MG/L                                      
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
      Fat, Necrosis                                    5 (71%)      6 (86%)      7 (70%)      4 (57%)                               
   Pancreas                                           (46)         (50)         (50)         (49)                                   
      Necrosis                                                      1 (2%)                                                          
      Acinus, Cytoplasmic Alteration                   2 (4%)       2 (4%)       2 (4%)                                             
   Salivary Glands                                    (49)         (50)         (50)         (50)                                   
      Atrophy                                          1 (2%)                                 2 (4%)                                
      Hyperplasia, Lymphoid                            3 (6%)       4 (8%)       6 (12%)      1 (2%)                                
   Stomach, Forestomach                               (49)         (50)         (50)         (50)                                   
      Diverticulum                                                  2 (4%)       1 (2%)                                             
      Erosion                                          1 (2%)                    1 (2%)       2 (4%)                                
      Inflammation, Chronic                            3 (6%)       1 (2%)       3 (6%)       6 (12%)                               
      Ulcer                                            2 (4%)       2 (4%)       2 (4%)       2 (4%)                                
      Epithelium, Hyperplasia                          4 (8%)       3 (6%)       4 (8%)       7 (14%)                               
      Epithelium, Hyperplasia, Focal                                             1 (2%)       1 (2%)                                
   Stomach, Glandular                                 (47)         (50)         (50)         (50)                                   
      Erosion                                          2 (4%)       2 (4%)       1 (2%)                                             
      Glands, Hyperplasia                                           1 (2%)                                                          
   Tooth                                              (5)          (6)                                                              
      Malformation                                     5 (100%)     6 (100%)                                                        
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Heart                                              (49)         (50)         (50)         (50)                                   
      Cardiomyopathy                                   1 (2%)       1 (2%)                                                          
      Inflammation, Chronic                            1 (2%)                                                                       
      Mineralization                                   3 (6%)                    2 (4%)       1 (2%)                                
      Myocardium, Necrosis                                          1 (2%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Cortex                                     (49)         (50)         (50)         (50)                                   
      Accessory Adrenal Cortical Nodule                7 (14%)      5 (10%)      4 (8%)       6 (12%)                               
      Hyperplasia, Focal                               4 (8%)       7 (14%)      5 (10%)      1 (2%)                                
      Hypertrophy                                      1 (2%)                                 1 (2%)                                
      Hypertrophy, Focal                              12 (24%)     11 (22%)     13 (26%)      6 (12%)                               
      Capsule, Hyperplasia                             7 (14%)      4 (8%)       1 (2%)       5 (10%)                               
   Adrenal Medulla                                    (49)         (50)         (50)         (50)                                   
      Hyperplasia                                      1 (2%)       1 (2%)                    1 (2%)                                
   Islets, Pancreatic                                 (46)         (50)         (50)         (49)                                   
      Atrophy                                                                                 1 (2%)                                
      Hyperplasia                                     34 (74%)     32 (64%)     26 (52%)     13 (27%)                               
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page    9                                                              
                                                                                                                                   
NTP Experiment-Test: 96017-06         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                         WATER DISINFECTION BYPRODUCTS (DIBROMOACETIC ACID)                    Date: 05/19/04    
Route: DOSED WATER                                                                                                Time: 09:07:01    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         B6C3F1 MICE MALE                          0 MG/L       50 MG/L      500 MG/L     1000                                      
                                                                                          MG/L                                      
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ENDOCRINE SYSTEM - CONT                                                                                                             
   Parathyroid Gland                                  (45)         (47)         (49)         (47)                                   
      Cyst                                                          2 (4%)       3 (6%)       4 (9%)                                
   Pituitary Gland                                    (45)         (50)         (48)         (48)                                   
      Pars Distalis, Cyst                              7 (16%)      7 (14%)      7 (15%)      5 (10%)                               
      Pars Distalis, Hyperplasia, Focal                1 (2%)                    1 (2%)                                             
   Thyroid Gland                                      (48)         (50)         (50)         (50)                                   
      Degeneration, Cystic                             5 (10%)      8 (16%)      3 (6%)       6 (12%)                               
      Follicular Cell, Hyperplasia                     3 (6%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Epididymis                                         (49)         (50)         (50)         (50)                                   
      Atypia Cellular                                  5 (10%)      4 (8%)       2 (4%)       6 (12%)                               
      Granuloma Sperm                                  1 (2%)       2 (4%)       2 (4%)       2 (4%)                                
      Spermatocele                                     1 (2%)                                 1 (2%)                                
   Preputial Gland                                    (49)         (50)         (50)         (50)                                   
      Cyst                                            25 (51%)     26 (52%)     33 (66%)     33 (66%)                               
      Inflammation, Chronic                           21 (43%)     30 (60%)     24 (48%)     28 (56%)                               
   Prostate                                           (48)         (50)         (50)         (49)                                   
      Inflammation, Chronic                                         4 (8%)                    1 (2%)                                
   Seminal Vesicle                                    (49)         (50)         (50)         (50)                                   
      Degeneration                                     3 (6%)       5 (10%)      1 (2%)                                             
      Inflammation, Chronic                            1 (2%)                                                                       
   Testes                                             (49)         (50)         (50)         (50)                                   
      Germinal Epithelium, Atrophy                     9 (18%)      4 (8%)       4 (8%)       8 (16%)                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Bone Marrow                                        (47)         (50)         (50)         (50)                                   
      Angiectasis                                                                             1 (2%)                                
      Depletion Cellular                               1 (2%)                                                                       
      Hyperplasia                                     22 (47%)     22 (44%)     28 (56%)     32 (64%)                               
   Lymph Node                                         (1)          (2)          (5)          (1)                                    
      Bronchial, Hyperplasia, Lymphoid                                           1 (20%)                                            
      Iliac, Ectasia                                                1 (50%)                                                         
      Inguinal, Hyperplasia, Lymphoid                                            1 (20%)                                            
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page   10                                                              
                                                                                                                                   
NTP Experiment-Test: 96017-06         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                         WATER DISINFECTION BYPRODUCTS (DIBROMOACETIC ACID)                    Date: 05/19/04    
Route: DOSED WATER                                                                                                Time: 09:07:01    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         B6C3F1 MICE MALE                          0 MG/L       50 MG/L      500 MG/L     1000                                      
                                                                                          MG/L                                      
____________________________________________________________________________________________________________________________________
                                                                                                                                    
HEMATOPOIETIC SYSTEM - CONT                                                                                                         
      Inguinal, Pigmentation                                        1 (50%)                                                         
      Mediastinal, Hyperplasia, Lymphoid               1 (100%)                  1 (20%)                                            
      Mediastinal, Pigmentation                                                               1 (100%)                              
      Pancreatic, Hyperplasia, Lymphoid                                          1 (20%)                                            
   Lymph Node, Mandibular                             (48)         (50)         (48)         (48)                                   
      Atrophy                                          5 (10%)      2 (4%)       3 (6%)       7 (15%)                               
      Hematopoietic Cell Proliferation                 1 (2%)                                                                       
      Hemorrhage                                       1 (2%)                    1 (2%)                                             
      Hyperplasia, Lymphoid                           15 (31%)     14 (28%)      6 (13%)      7 (15%)                               
      Pigmentation                                     7 (15%)      8 (16%)      1 (2%)       7 (15%)                               
   Lymph Node, Mesenteric                             (46)         (49)         (49)         (47)                                   
      Atrophy                                          4 (9%)       2 (4%)       1 (2%)       9 (19%)                               
      Hematopoietic Cell Proliferation                 1 (2%)       1 (2%)       3 (6%)       3 (6%)                                
      Hemorrhage                                       8 (17%)      5 (10%)      9 (18%)      7 (15%)                               
      Hyperplasia, Lymphoid                            2 (4%)       8 (16%)      3 (6%)       6 (13%)                               
      Hyperplasia, Plasma Cell                                                   1 (2%)                                             
   Spleen                                             (47)         (50)         (50)         (50)                                   
      Angiectasis                                                                             1 (2%)                                
      Hematopoietic Cell Proliferation                18 (38%)     20 (40%)     28 (56%)     38 (76%)                               
      Pigmentation                                                  1 (2%)       1 (2%)       1 (2%)                                
      Lymphoid Follicle, Atrophy                       4 (9%)       7 (14%)      3 (6%)       8 (16%)                               
      Lymphoid Follicle, Hyperplasia                   3 (6%)       6 (12%)      6 (12%)      6 (12%)                               
   Thymus                                             (42)         (45)         (46)         (47)                                   
      Atrophy                                         14 (33%)     16 (36%)     12 (26%)     22 (47%)                               
      Hyperplasia, Lymphoid                                         1 (2%)       1 (2%)       1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Skin                                               (49)         (50)         (50)         (50)                                   
      Cyst Epithelial Inclusion                                     2 (4%)                                                          
      Ulcer                                            3 (6%)       2 (4%)                    3 (6%)                                
      Epidermis, Hyperplasia                           3 (6%)       2 (4%)                    3 (6%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   Bone                                               (49)         (50)         (50)         (50)                                   
      Hyperostosis                                                  1 (2%)                                                          
      Cranium, Hyperostosis                            1 (2%)                                 1 (2%)                                
   Skeletal Muscle                                    (1)          (1)                       (1)                                    
      Atrophy                                                       1 (100%)                                                        
____________________________________________________________________________________________________________________________________
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page   11                                                              
                                                                                                                                   
NTP Experiment-Test: 96017-06         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                         WATER DISINFECTION BYPRODUCTS (DIBROMOACETIC ACID)                    Date: 05/19/04    
Route: DOSED WATER                                                                                                Time: 09:07:01    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         B6C3F1 MICE MALE                          0 MG/L       50 MG/L      500 MG/L     1000                                      
                                                                                          MG/L                                      
____________________________________________________________________________________________________________________________________
                                                                                                                                    
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Peripheral Nerve                                   (2)          (2)          (1)                                                 
      Atrophy                                                       1 (50%)      1 (100%)                                           
   Spinal Cord                                        (2)          (2)          (1)                                                 
      Gliosis                                          1 (50%)                                                                      
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Lung                                               (49)         (50)         (50)         (50)                                   
      Edema                                            2 (4%)                    1 (2%)       2 (4%)                                
      Hemorrhage                                       2 (4%)                                 4 (8%)                                
      Hyperplasia, Lymphoid                            3 (6%)                    1 (2%)                                             
      Infiltration Cellular, Histiocyte                2 (4%)       6 (12%)      3 (6%)       6 (12%)                               
      Metaplasia, Osseous                              1 (2%)       2 (4%)                    1 (2%)                                
      Alveolar Epithelium, Hyperplasia                 2 (4%)       6 (12%)      6 (12%)      7 (14%)                               
      Bronchiole, Hyperplasia                                                                 1 (2%)                                
   Nose                                               (48)         (50)         (50)         (50)                                   
      Foreign Body                                                               1 (2%)                                             
      Inflammation, Chronic                            1 (2%)       1 (2%)       3 (6%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   Eye                                                (49)         (50)         (50)         (50)                                   
      Atrophy                                                       1 (2%)                                                          
      Cataract                                                      1 (2%)       1 (2%)       5 (10%)                               
      Inflammation, Chronic                                                      2 (4%)       2 (4%)                                
      Bilateral, Cataract                                                                     1 (2%)                                
      Cornea, Hyperplasia                                                        1 (2%)       1 (2%)                                
   Harderian Gland                                    (49)         (50)         (50)         (50)                                   
      Cyst                                                          1 (2%)                                                          
      Hyperplasia, Focal                               5 (10%)      1 (2%)       1 (2%)       1 (2%)                                
   Lacrimal Gland                                                  (1)                                                              
      Cyst                                                          1 (100%)                                                        
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (49)         (50)         (50)         (50)                                   
      Cyst                                             9 (18%)     13 (26%)     14 (28%)     11 (22%)                               
      Hydronephrosis                                   4 (8%)       2 (4%)                    4 (8%)                                
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page   12                                                              
                                                                                                                                   
NTP Experiment-Test: 96017-06         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                         WATER DISINFECTION BYPRODUCTS (DIBROMOACETIC ACID)                    Date: 05/19/04    
Route: DOSED WATER                                                                                                Time: 09:07:01    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         B6C3F1 MICE MALE                          0 MG/L       50 MG/L      500 MG/L     1000                                      
                                                                                          MG/L                                      
____________________________________________________________________________________________________________________________________
                                                                                                                                    
URINARY SYSTEM - CONT                                                                                                               
      Hyperplasia, Lymphoid                            5 (10%)      5 (10%)      6 (12%)      5 (10%)                               
      Infarct                                          3 (6%)       7 (14%)      4 (8%)       5 (10%)                               
      Inflammation, Suppurative                                     1 (2%)                    1 (2%)                                
      Metaplasia, Osseous                              6 (12%)      3 (6%)       2 (4%)       2 (4%)                                
      Nephropathy                                     36 (73%)     44 (88%)     42 (84%)     39 (78%)                               
      Papilla, Necrosis                                                                       1 (2%)                                
      Renal Tubule, Accumulation, Hyaline Droplet                                1 (2%)                                             
      Renal Tubule, Dilatation                         1 (2%)       3 (6%)                    1 (2%)                                
      Renal Tubule, Hyperplasia                        1 (2%)       1 (2%)       1 (2%)       3 (6%)                                
      Renal Tubule, Necrosis                           1 (2%)                                                                       
      Renal Tubule, Pigmentation                       1 (2%)       3 (6%)       2 (4%)       7 (14%)                               
      Transitional Epithelium, Hyperplasia                                       1 (2%)                                             
   Urethra                                                         (3)                                                              
      Angiectasis                                                   3 (100%)                                                        
      Inflammation, Chronic Active                                  3 (100%)                                                        
   Urinary Bladder                                    (49)         (50)         (50)         (49)                                   
      Edema                                                                      1 (2%)                                             
      Hemorrhage                                                    1 (2%)                                                          
      Hyperplasia, Lymphoid                                         1 (2%)       1 (2%)                                             
      Inflammation, Chronic                                                                   1 (2%)                                
      Transitional Epithelium, Hyperplasia                                       1 (2%)       1 (2%)                                
                                                                                                                                    
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                             Page   13                                                              
                                                                                                                                   
                             ------------------------------------------------------------                                           
                             ----------              END OF REPORT             ----------                                           
                             ------------------------------------------------------------